Patients with asymptomatic WM are managed by watchful waiting and monitoring every 3-6 months. Patients who meet the criteria for WM on the basis of elevated serum IgM and/or bone marrow lymphoplasmacytic infiltration but who do not have end-organ damage are considered to have smoldering WM (also referred to as "indolent WM"), for which no treatment is indicated. Repeat testing for IgM elevations, serum viscosity, and careful observation for symptom development will guide future management.
A prednisone taper, angiotensin-converting enzyme inhibitor therapy with increased fluid intake, and high-dose combination chemotherapy are not appropriate treatment options for patients with asymptomatic WM.
Learn more about asymptomatic WM.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Emmanuel C. Besa. Fast Five Quiz: Can You Treat Waldenström Macroglobulinemia? - Medscape - Mar 22, 2022.